butylscopolammonium bromide has been researched along with Prostatic Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albers, P; Antoch, G; Arsov, C; Blondin, D; Quentin, M; Rabenalt, R; Rubbert, C; Schimmöller, L; Schmaltz, AK; Ullrich, T | 1 |
| Ashley, SA; deSouza, NM; Fisher, C; Morgan, VA; Parker, C; Payne, GS; Riches, SF; Vanas, NJ | 1 |
| Doyle, CA; Hruby, G; Loadsman, JA | 1 |
| Busch, J; Franiel, T; Hamm, B; Rief, M; Scheurig, C; Taupitz, M; Wagner, M | 1 |
1 trial(s) available for butylscopolammonium bromide and Prostatic Neoplasms
| Article | Year |
|---|---|
Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostate.
Topics: Aged; Artifacts; Butylscopolammonium Bromide; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Parasympatholytics; Prostate; Prostatic Neoplasms; ROC Curve | 2018 |
3 other study(ies) available for butylscopolammonium bromide and Prostatic Neoplasms
| Article | Year |
|---|---|
Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer.
Topics: Aged; Butylscopolammonium Bromide; Diffusion Magnetic Resonance Imaging; Humans; Injections, Intramuscular; Male; Middle Aged; Neoplasm Staging; Parasympatholytics; Prospective Studies; Prostatic Neoplasms; Sensitivity and Specificity | 2008 |
An audit of analgesia requirements for high-dose-rate prostate brachytherapy.
Topics: Acetaminophen; Aged; Aged, 80 and over; Analgesia; Analgesics; Analgesics, Non-Narcotic; Analgesics, Opioid; Antiemetics; Brachytherapy; Butylscopolammonium Bromide; Humans; Male; Medical Audit; Middle Aged; Morphine; Muscarinic Antagonists; Oxycodone; Parasympatholytics; Postoperative Care; Prostatic Neoplasms; Radiotherapy Dosage; Retrospective Studies | 2008 |
Effect of butylscopolamine on image quality in MRI of the prostate.
Topics: Aged; Artifacts; Butylscopolammonium Bromide; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Injections, Intramuscular; Magnetic Resonance Imaging; Male; Middle Aged; Muscarinic Antagonists; Prostate; Prostatic Neoplasms; Retrospective Studies | 2010 |